Advancing global health through non-invasive metabolic detection
Executive Chairman
Chief Executive Officer
Chief Technology Officer, Director International
Chief Scientific Officer, MD, PHD
Director Strategic Initiatives
Director Business Operations
Director, Revenue Cycle and Payer Relations
Dedicated to providing expert healthcare advanced technology, experienced professionals, and personalized treatments to ensure your well-being and a healthier future.
“MASH accounts for about 20-25% of all MASLD patients and can be challenging to diagnose… LIVERFASt™, uniquely gives us an opportunity to identify these patients and direct them to appropriate care that may help prevent progression of their disease.”
Chief Medical Officer (CMO), Summit Clinical Research. Director of the Steatotic Liver Program. Clinical Research Institute of Ohio (CRIOH)
“LIVERFASt™ is a very reliable test that facilitates my care of MASH patients”
Director of Liver Transplant Program at Houston Methodist Transplant Center and Director of Liver Associates of Texas Houston, TX
“In my opinion the science and subsequent validation of the LIVERFASt™ test, fulfills a strong and unmet need for accurate diagnosis and monitoring of MASH .”
Executive Medical Director Scientific Affairs, Innovation and New Technology, Methodist Health System, Plano, TX
Contact our sales representative to inquire more about LIVERFASt™ and how it can help you and your patients improve their liver health.
